|D004211||Disseminated Intravascular Coagulation NIH||0.45|
|D020141||Hemostatic Disorders NIH||0.26|
|D001778||Blood Coagulation Disorders NIH||0.26|
There is one clinical trial.
Presenting outline of the steps taken by our team to set up a Covid Care facility within the Prison setting. The facility was set up at Camp Jail (Lahore District Jail) located on Ferozpur Road, Lahore.
Description: Confirmed by double negative PCR results of specimen obtained via nasopharyngeal swabsMeasure: Recovery Time: 30 days
Description: Death of any of the patients who had tested positive at the Camp JailMeasure: Mortality Time: 30 days
Description: Any patient requiring admission to intensive care unit due to developing symptomsMeasure: ICU admission Time: 30 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports